Jason Amello
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jason Amello
Jason Amello is recorded as CFO at Candel Therapeutics, Inc. (CADL). Candel Therapeutics, Inc. reported in an 8-K filed September 7, 2022 that Jason Amello was appointed Chief Financial Officer, effective September 21, 2022.
“Jason Amello as the Company's Chief Financial Officer, effective September 21, 2022.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-09-21–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Candel Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Paul Peter Tak CEO, Board Member
- Charles Schoch CFO
- Diem Nguyen, Ph.D. Board Member
- Edward J. Benz Board Member
- Gary Nabel Board Member
- Joseph Papa Board Member
- Maha Radhakrishnan Board Member
- Maha Radhakrishnan, M.D. Board Member
- Martine Zimmermann Board Member
- Nicoletta Loggia, Ph.D., R.Ph. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.